Boston Scientific Corporation
BSXLast close · Oct 16, 202644.39+0.25 (+0.57%)
Market cap$64.3B
Key indicators
Revenue21.0B+13.5% on a year earlier
9.8B
10.7B
9.9B
11.9B
12.7B
14.2B
16.7B
20.1B
21.0B
21.2B
22.2B
23.7B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 9.8B | 10.7B+9.3% | 9.9B−7.7% | 11.9B+19.9% | 12.7B+6.7% | 14.2B+12.3% | 16.7B+17.6% | 20.1B+19.9% | 21.0B+13.5% | 21.2B | 22.2B | 23.7B | |
| — | 9.3% | -7.7% | 19.9% | 6.7% | 12.3% | 17.6% | 19.9% | 13.5% | 5.6% | 4.8% | 6.6% | |
| $1.19 | $3.33+179.8% | -$0.08−102.4% | $0.69+962.5% | $0.45−34.8% | $1.07+137.8% | $1.25+16.8% | $1.94+55.2% | $2.47+47.0% | $3.25 | $3.39 | $3.74 | |
| Profitability | ||||||||||||
| 71.4% | 71.0%−0.4 pt | 65.0%−5.9 pt | 68.8%+3.7 pt | 68.8%+0.0 pt | 69.5%+0.7 pt | 68.6%−0.9 pt | 69.0%+0.4 pt | 69.9%+1.7 pt | · | · | · | |
| 15.3% | 14.1%−1.2 pt | -0.8%−14.9 pt | 10.1%+10.9 pt | 13.0%+2.9 pt | 16.5%+3.5 pt | 15.5%−0.9 pt | 18.0%+2.5 pt | 19.8%+2.8 pt | · | · | · | |
| 17.0% | 43.8%+26.8 pt | -0.8%−44.6 pt | 8.8%+9.6 pt | 5.5%−3.3 pt | 11.2%+5.7 pt | 11.0%−0.2 pt | 14.4%+3.4 pt | 17.5%+4.0 pt | · | · | · | |
| — | — | — | 6.3% | 4.0%−2.3 pt | 8.3%+4.3 pt | 8.5%+0.2 pt | 11.9%+3.5 pt | — | · | · | · | |
| Cash | ||||||||||||
| -6.0M | 1.4B+23016.7% | 1.1B−17.7% | 1.3B+16.3% | 938.0M−28.7% | 1.8B+91.0% | 2.6B+47.6% | 3.7B+38.3% | 3.6B+4.0% | · | · | · | |
| -0.1% | 12.8%+12.9 pt | 11.4%−1.4 pt | 11.1%−0.3 pt | 7.4%−3.7 pt | 12.6%+5.2 pt | 15.8%+3.2 pt | 18.2%+2.4 pt | 17.3%−1.6 pt | · | · | · | |
| 0 | 0 | 28.0M | 55.0M+96.4% | 55.0M+0.0% | 28.0M−49.1% | 0−100.0% | — | — | · | · | · | |
| Balance sheet | ||||||||||||
| — | — | — | 0.55x | 0.51x−0.04x | 0.47x−0.04x | 0.49x+0.02x | 0.47x−0.02x | 0.51x−0.01x | · | · | · | |
| 1.40B | 1.41B+0.7% | 1.42B+0.4% | 1.43B+1.2% | 1.44B+0.4% | 1.46B+1.7% | 1.49B+1.5% | 1.49B+0.6% | 1.47B−1.3% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.